Discuss generation of B-cell receptor (BCR) and antibody diversity, focusing on:
Genetic organisation of immunoglobulin (Ig) loci.
Molecular mechanisms that enlarge the antibody repertoire:
V-(D)-J recombination & junctional diversity.
Somatic hypermutation (SHM).
Class-switch recombination (CSR) and variable heavy (H)/light (L) chain pairing.
Antibody repertoire = total number of distinct antigen‐binding specificities in one individual.
Potential specificities ≈ 10^{8} (≈ 1\times10^{8} – 10^{11} quoted).
Human protein-coding genes ≈ 2.5\times10^{4}; therefore diversity cannot arise from one gene per antibody → requires somatic DNA rearrangement.
Susumu Tonegawa (1976) discovered somatic recombination in lymphocytes → 1987 Nobel Prize.
Combinatorial diversity from gene-segment rearrangement ( V-(D)-J ).
Junctional diversity during those rearrangements (imprecise cutting/adding nucleotides).
Somatic hypermutation after antigen activation.
Variable combinations of independently generated H and L chains, including CSR.
Chromosomal localisation:
Heavy-chain (H) locus (isotypes \alpha,\,\delta,\,\varepsilon,\,\gamma,\,\mu) → chromosome 14.
Light-chain \lambda locus → chromosome 22.
Light-chain \kappa locus → chromosome 2.
Germ-line arrangement (each locus contains):
V (variable), D (diversity – H only), J (joining), C (constant) gene segments.
Order on chromosome (5′→3′): multiple V → multiple D (H only) → multiple J → series of C genes (isotypes).
Light chains ( \kappa,\,\lambda )
Require one recombination event: one random V joins one random J → \text{V}J.
Heavy chains
First: one random D joins one random J ( D\,J ).
Second: one random V joins the pre-formed DJ → V\,DJ.
\lambda-L: 30\,V \times 4\,J = 1.2\times10^{2} combinations.
\kappa-L: 40\,V \times 5\,J = 2.0\times10^{2} combinations.
Heavy: 40\,V \times 25\,D \times 6\,J = 6.0\times10^{3} combinations.
Potential unique H+L pairings:
\begin{aligned}
6.0\times10^{3}\;H\times(2.0\times10^{2}+1.2\times10^{2})\;L &\approx 2.0\times10^{6}
\end{aligned}
(Only from 150 total germ-line segments → clearly insufficient vs 10^{8} repertoire → need further mechanisms.)
RSS = conserved non-coding motifs flanking each V, D, J segment.
Structure: heptamer (7 bp) – spacer (12 bp or 23 bp) – nonamer (9 bp).
12/23 rule: segments flanked by a 12 bp spacer RSS can recombine only with segments flanked by 23 bp spacer RSS → ensures correct gene-segment order (e.g., prevents V joining directly to J in heavy locus).
RAG-1 & RAG-2: recognise RSSs, introduce double-strand breaks.
DNA-PK (DNA‐dependent protein kinase) + Artemis nuclease: open hairpins and create variability.
TdT (terminal deoxynucleotidyl transferase): non-template N-nucleotide addition.
DNA polymerase, exonucleases, DNA ligase: process & seal joints.
RAG-1/2 bind paired RSSs, cleave one DNA strand → free 3′-OH attacks opposite strand → hairpin at coding ends + blunt signal ends.
DNA-PK:Artemis randomly nicks hairpin → generates palindromic (P) nucleotides.
Exonuclease trimming may delete bases.
TdT adds up to 15 random N nucleotides.
DNA polymerase fills gaps; ligase forms coding joint (imprecise, highly diverse) and precise signal joint (excised circle).
Diversity concentrated in CDR3 (antigen-binding hotspot) due to:
Variable hairpin nick sites (P nucleotides).
Random N-nucleotide addition by TdT.
Exonuclease nucleotide deletions.
Generates frame-shift/stop codons → many rearrangements non-productive (fails quality control).
Order of events in bone marrow (hematopoiesis):
Stem cell → early pro-B: D!J heavy rearrangement begins.
Late pro-B: V\,DJ rearrangement.
Large pre-B: expression of μ heavy chain with surrogate light chain on surface (pre-B receptor) → signaling halts further H rearrangement (allelic exclusion).
Small pre-B: light-chain VJ rearrangement.
Immature B: complete IgM (μ heavy + genuine light) on surface.
Mature naïve B: alternative RNA splicing co-expresses IgM (μ) and IgD (δ) BCRs.
Allelic exclusion guarantees one antibody specificity per B cell.
Bone marrow central deletion: immature IgM+ B cells recognizing self undergo apoptosis (clonal deletion).
Spleen (white pulp) final maturation:
Further deletion: IgM/IgD dual-expressing B cells tested again.
Survivors = mature naïve B cells entering circulation.
Antigen sources:
Tissue-derived antigens drain to lymph nodes/follicles.
Blood-borne antigens captured in spleen.
Naïve B cell must:
Recognise free or APC-presented antigen via BCR.
Receive help from cognate CD4⁺ T helper (TH) cells.
Outcomes after activation (germinal centre reaction):
Somatic hypermutation.
Class-switch recombination.
Massive clonal expansion → plasma cells or memory B cells.
Failure → apoptosis.
Timing/location: within 1 week of antigen exposure in rapidly dividing germinal-centre B cells.
Enzyme: Activation-induced cytidine deaminase (AID).
Deaminates cytidine → uracil in DNA, triggering error-prone repair → point mutations.
Target region: V-region exons (especially CDR1, CDR2, CDR3) in both H & L chains; constant regions spared.
Consequences:
Creates variants with higher, equal, or lower affinity.
Positive selection by follicular dendritic cells & TH help retains high-affinity clones → affinity maturation (later antibodies bind stronger).
Initial antibody is always IgM (μ constant region) – sometimes co-expressed IgD by splicing.
CSR replaces Cμ/Cδ with downstream constant region genes ( \gamma,\alpha,\varepsilon …) without altering antigen specificity (VDJ untouched).
Requires B cell activation signals: CD40–CD40L plus cytokines from TH cells.
Switch (S) regions (highly repetitive DNA) upstream of each constant gene.
AID initiates double-strand breaks within the two selected S regions.
Looping out and deletion of intervening DNA joins VDJ to new CH gene → irreversible; excised DNA lost as circle.
Cytokines dictate target isotype:
IL-4 → IgG1, IgE.
TGF-β → IgA, IgG2b.
IFN-γ → IgG3, IgG2a (mouse isotypes; human parallels similar).
Preserves antigen specificity while altering effector functions:
IgG subclasses: opsonisation, placental transfer, complement activation.
IgA: mucosal immunity (dimeric form via J chain).
IgE: mast-cell binding, parasite & allergy responses.
IgM: pentameric (10 binding sites) → strong agglutination, complement activation.
\textbf{1.} V(D)J combinational choice.
\textbf{2.} Junctional diversification (P + N addition/deletion).
\textbf{3.} Pairing of independently rearranged H & L chains.
\textbf{4.} Somatic hypermutation post-activation.
\textbf{5.} Class switching yields further functional variety (not new specificity).
Plasma cells: antibody factories; no surface BCR; most die in 1–2 weeks, some return to bone marrow as long-lived plasma cells (maintain serum antibody).
Memory B cells: quiescent, circulate for years; rapid secondary response.
Immune tolerance educates B/T cells to ignore self.
Vast diversity means some BCRs intrinsically bind self (e.g., insulin) → central/peripheral deletion or anergy required.
Failure leads to autoimmune disease (type 1 diabetes, SLE, etc.).
Antibody quality increases over time (affinity maturation).
Clonal selection ensures self-tolerance and pathogen focus.
Immunological memory provides rapid, heightened secondary responses.
"Describe the genetic organisation of the heavy and light chain immunoglobulin loci and discuss the molecular mechanisms that lead to antibody diversity." Prepare to integrate points above: loci structure, RSS & enzymes, combinatorial + junctional diversity, SHM, CSR, functional outcomes.
Kuby Immunology 8e – Ch 6.
Janeway’s Immunobiology – Ch 3, 5, 8, 9.
Parham – The Immune System 3e – Ch 3, 5, 8, 9.
Roitt’s Essential Immunology (relevant chapters).